Cryoport, Inc.
CYRXNasdaqCIK 1124524HealthcareFiscal year ends Dec 31
Reports and events: 317 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0617:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-092107 |
| 2026-08-0616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092064 |
| 2026-06-0917:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-071892 |
| 2026-05-0514:36 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-055513 |
| 2026-05-0416:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-054942 |
| 2026-04-2216:30 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001140361-26-016129 |
| 2026-03-0516:53 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-024180 |
| 2026-03-0317:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-022940 |
| 2025-11-0614:33 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107640 |
| 2025-11-0417:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-106421 |
| 2025-08-1221:57 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011127 |
| 2025-08-0617:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074314 |
| 2025-06-1315:55 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008613 |
| 2025-06-1009:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-058019 |
| 2025-05-0817:18 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007012 |
| 2025-05-0716:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045557 |
| 2025-04-2516:30 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0001140361-25-015777 |
| 2025-03-3108:17 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029642 |
| 2025-03-0717:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002509 |
| 2025-03-0417:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-020404 |
| 2024-11-0716:56 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014896 |
| 2024-11-0716:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115344 |
| 2024-08-0814:55 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011562 |
| 2024-08-0617:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086344 |
| 2024-08-0616:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-086305 |
| 2024-05-2217:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-064333 |
| 2024-05-0819:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007133 |
| 2024-05-0716:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058082 |
| 2024-04-0316:18 ET | DEF 14A | Proxy statementPeriod 2024-05-17 | 0001140361-24-017597 |
| 2024-03-1317:26 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003128 |
| 2024-03-1216:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-033491 |
| 2024-02-1516:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-024562 |
| 2023-11-1516:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-118697 |
| 2023-11-0914:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018511 |
| 2023-11-0816:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115766 |
| 2023-08-0917:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-089376 |
| 2023-08-0916:47 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001410578-23-001635 |
| 2023-07-1216:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-080348 |
| 2023-05-1617:29 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-061489 |
| 2023-05-0417:22 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001410578-23-000882 |
| 2023-05-0416:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-056041 |
| 2023-03-3116:36 ET | DEF 14A | Proxy statement | 0001140361-23-015386 |
| 2023-03-2817:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-037784 |
| 2023-03-1516:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-23-032821 |
| 2023-02-2817:08 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001410578-23-000188 |
| 2023-02-2316:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-024795 |
| 2022-11-0415:14 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001410578-22-002947 |
| 2022-11-0316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-114437 |
| 2022-08-0417:04 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001410578-22-002045 |
| 2022-08-0416:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-086174 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.